Skip to main content
Top
Published in: Journal of Immigrant and Minority Health 2/2013

01-04-2013 | Original Paper

Acute Viral Hepatitis in the United States–Mexico Border Region: Data from the Border Infectious Disease Surveillance (BIDS) Project, 2000–2009

Authors: Philip R. Spradling, Jian Xing, Alba Phippard, Maureen Fonseca-Ford, Sonia Montiel, Norma Luna Guzmán, Roberto Vázquez Campuzano, Gilberto Vaughan, Guo-liang Xia, Jan Drobeniuc, Saleem Kamili, Ricardo Cortés-Alcalá, Stephen H. Waterman, the BIDS Investigators

Published in: Journal of Immigrant and Minority Health | Issue 2/2013

Login to get access

Abstract

Little is known about the characteristics of acute viral hepatitis cases in the United States (US)–Mexico border region. We analyzed characteristics of acute viral hepatitis cases collected from the Border Infectious Disease Surveillance Project from January 2000–December 2009. Over the study period, 1,437 acute hepatitis A, 311 acute hepatitis B, and 362 acute hepatitis C cases were reported from 5 Mexico and 2 US sites. Mexican hepatitis A cases most frequently reported close personal contact with a known case, whereas, US cases most often reported cross-border travel. Injection drug use was common among Mexican and US acute hepatitis B and C cases. Cross-border travel during the incubation period was common among acute viral hepatitis cases in both countries. Assiduous adherence to vaccination and prevention guidelines in the US is needed and strategic implementation of hepatitis vaccination and prevention programs south of the border should be considered.
Appendix
Available only for authorised users
Literature
4.
go back to reference Doyle T, Bryan R. Infectious disease morbidity in the U.S. region bordering Mexico. J Infect Dis. 2000;182:1503–10. Epub 2000 September 27. Doyle T, Bryan R. Infectious disease morbidity in the U.S. region bordering Mexico. J Infect Dis. 2000;182:1503–10. Epub 2000 September 27.
5.
go back to reference CDC. Preventing and controlling tuberculosis along the U.S.–Mexico Border. MMWR 2001;50(RR1):1–2. CDC. Preventing and controlling tuberculosis along the U.S.–Mexico Border. MMWR 2001;50(RR1):1–2.
6.
go back to reference Strathdee SA, Magis-Rodriguez C. Mexico’s evolving HIV epidemic. J Am Med Assoc. 2008;300(5):571–3.CrossRef Strathdee SA, Magis-Rodriguez C. Mexico’s evolving HIV epidemic. J Am Med Assoc. 2008;300(5):571–3.CrossRef
7.
go back to reference Weinberg M, Waterman S, Lucas CA, et al. The U.S.–Mexico border infectious disease surveillance project: establishing binational border surveillance. Emerg Infect Dis. 2003;9:97–102.PubMedCrossRef Weinberg M, Waterman S, Lucas CA, et al. The U.S.–Mexico border infectious disease surveillance project: establishing binational border surveillance. Emerg Infect Dis. 2003;9:97–102.PubMedCrossRef
8.
go back to reference CDC. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR 2003;52(RR-3):1–13. CDC. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR 2003;52(RR-3):1–13.
9.
go back to reference CDC. Surveillance for acute viral hepatitis—United States, 2007. MMWR 2009;58(SS-3):1–27. CDC. Surveillance for acute viral hepatitis—United States, 2007. MMWR 2009;58(SS-3):1–27.
10.
go back to reference Tapia-Conver R, Santos JI, Cavalcanti AM, et al. Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg. 1999;61:825–9. Tapia-Conver R, Santos JI, Cavalcanti AM, et al. Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg. 1999;61:825–9.
11.
go back to reference García-Juárez I, Solorzano Santos F, Alvarez-y-Munoz MT, et al. Is there a shift in the epidemiology of hepatitis A in Mexican children? Rev Invest Clin. 2008;60:292–6.PubMed García-Juárez I, Solorzano Santos F, Alvarez-y-Munoz MT, et al. Is there a shift in the epidemiology of hepatitis A in Mexican children? Rev Invest Clin. 2008;60:292–6.PubMed
12.
go back to reference Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004;132:1005–22.PubMedCrossRef Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004;132:1005–22.PubMedCrossRef
13.
go back to reference Román S, Panduro A, Aguilar-Gutiérrez Y, et al. A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review. Hepatol Int. 2009;3:343–55.PubMedCrossRef Román S, Panduro A, Aguilar-Gutiérrez Y, et al. A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review. Hepatol Int. 2009;3:343–55.PubMedCrossRef
14.
go back to reference Santos-López G, Sosa-Jurado F, Vallejo-Ruíz V, et al. Prevalence of hepatitis C virus in the Mexican population: a systematic review. J Infect. 2008;56:281–90.PubMedCrossRef Santos-López G, Sosa-Jurado F, Vallejo-Ruíz V, et al. Prevalence of hepatitis C virus in the Mexican population: a systematic review. J Infect. 2008;56:281–90.PubMedCrossRef
15.
go back to reference Chiquete E, Panduro A. Low prevalence of anti-hepatitis C virus antibodies in Mexico: a systematic review. Intervirology. 2007;50:1–8.PubMedCrossRef Chiquete E, Panduro A. Low prevalence of anti-hepatitis C virus antibodies in Mexico: a systematic review. Intervirology. 2007;50:1–8.PubMedCrossRef
16.
go back to reference White EF, Garfein RS, Brouwer KC, et al. Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Salud Pública de México 2007;49:165–72. White EF, Garfein RS, Brouwer KC, et al. Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Salud Pública de México 2007;49:165–72.
17.
go back to reference Vera de León L, Juárez Navarro JA, Díaz Gómez M, et al. Epidemiologic and situational panorama of hepatitis C in Mexico. Rev Gastroenterol Mex. 2005;70:25–32. Vera de León L, Juárez Navarro JA, Díaz Gómez M, et al. Epidemiologic and situational panorama of hepatitis C in Mexico. Rev Gastroenterol Mex. 2005;70:25–32.
18.
go back to reference Weinberg M, Hopkins J, Farrington L, Gresham L, Ginsberg M, Bell BP. Hepatitis A in Hispanic children who live along the United States–Mexico border: the role of international travel and food-borne exposures. Pediatrics. 2004;114:e68–73.PubMedCrossRef Weinberg M, Hopkins J, Farrington L, Gresham L, Ginsberg M, Bell BP. Hepatitis A in Hispanic children who live along the United States–Mexico border: the role of international travel and food-borne exposures. Pediatrics. 2004;114:e68–73.PubMedCrossRef
19.
go back to reference Jong EC. United States epidemiology of hepatitis A: influenced by immigrants visiting friends and relatives in Mexico? Am J Med. 2005;118 Suppl 10A:50S–57S. Jong EC. United States epidemiology of hepatitis A: influenced by immigrants visiting friends and relatives in Mexico? Am J Med. 2005;118 Suppl 10A:50S–57S.
20.
go back to reference Nainan OV, Xia G, Vaughan G, Margolis HS. Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev. 2006;19(1):63–79.PubMedCrossRef Nainan OV, Xia G, Vaughan G, Margolis HS. Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev. 2006;19(1):63–79.PubMedCrossRef
21.
go back to reference Nainan OV, Armstrong GL, Hana XH, Williams I, Bell BP, Margolis HS. Hepatitis A molecular epidemiology in the United States, 1996–1997: sources of infection and implications of vaccination policy. J Infect Dis. 2005;191:957–63.PubMedCrossRef Nainan OV, Armstrong GL, Hana XH, Williams I, Bell BP, Margolis HS. Hepatitis A molecular epidemiology in the United States, 1996–1997: sources of infection and implications of vaccination policy. J Infect Dis. 2005;191:957–63.PubMedCrossRef
22.
go back to reference Hand WL, Vasquez Y. Risk factors for hepatitis C on the Texas–Mexico border. Am J Gastroenterol. 2005;100:2180–5.PubMedCrossRef Hand WL, Vasquez Y. Risk factors for hepatitis C on the Texas–Mexico border. Am J Gastroenterol. 2005;100:2180–5.PubMedCrossRef
23.
go back to reference Samuel M, Doherty P, Bulterys M, et al. Association between heroin use, needle sharing and tattoos received in prison with Hepatitis B and Hepatitis C positivity among street-recruited injection drug users in New Mexico. USA. Epidemiol Infect. 2001;127:475–84. Samuel M, Doherty P, Bulterys M, et al. Association between heroin use, needle sharing and tattoos received in prison with Hepatitis B and Hepatitis C positivity among street-recruited injection drug users in New Mexico. USA. Epidemiol Infect. 2001;127:475–84.
24.
25.
go back to reference Van Damme P, Banatvala J, Fay O, et al. Hepatitis A booster vaccination: is there a need? Lancet. 2003;362:1065–71.PubMedCrossRef Van Damme P, Banatvala J, Fay O, et al. Hepatitis A booster vaccination: is there a need? Lancet. 2003;362:1065–71.PubMedCrossRef
26.
go back to reference Craig AS, Schaffner W. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med. 2004;350:476–81.PubMedCrossRef Craig AS, Schaffner W. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med. 2004;350:476–81.PubMedCrossRef
27.
go back to reference Dagan R, Leventhal A, Anis E, Slater P, Shouval D. National hepatitis A virus (HAV) immunization program aimed exclusively at toddlers in an endemic country resulting in >90% reduction in morbidity rate in all ages [Abstract #825], 40th Annual Meeting of the Infectious Diseases Society of America, 24–27 October 2002, Chicago. Dagan R, Leventhal A, Anis E, Slater P, Shouval D. National hepatitis A virus (HAV) immunization program aimed exclusively at toddlers in an endemic country resulting in >90% reduction in morbidity rate in all ages [Abstract #825], 40th Annual Meeting of the Infectious Diseases Society of America, 24–27 October 2002, Chicago.
28.
go back to reference Owen EC, Peddecord KM, Wang WW, et al. Hepatitis A vaccine uptake in San Diego County: Hispanic children are better immunized. Arch Pediatr Adolesc Med. 2005;159:971–6.PubMedCrossRef Owen EC, Peddecord KM, Wang WW, et al. Hepatitis A vaccine uptake in San Diego County: Hispanic children are better immunized. Arch Pediatr Adolesc Med. 2005;159:971–6.PubMedCrossRef
29.
go back to reference O’Rourke KM, Redlinger TE, Steege AM. Improving hepatitis B immunization among high-risk adolescents: a low-cost intervention on the Mexico-United States border. Rev Panam Salud Publica. 2001;9:228–33.PubMedCrossRef O’Rourke KM, Redlinger TE, Steege AM. Improving hepatitis B immunization among high-risk adolescents: a low-cost intervention on the Mexico-United States border. Rev Panam Salud Publica. 2001;9:228–33.PubMedCrossRef
Metadata
Title
Acute Viral Hepatitis in the United States–Mexico Border Region: Data from the Border Infectious Disease Surveillance (BIDS) Project, 2000–2009
Authors
Philip R. Spradling
Jian Xing
Alba Phippard
Maureen Fonseca-Ford
Sonia Montiel
Norma Luna Guzmán
Roberto Vázquez Campuzano
Gilberto Vaughan
Guo-liang Xia
Jan Drobeniuc
Saleem Kamili
Ricardo Cortés-Alcalá
Stephen H. Waterman
the BIDS Investigators
Publication date
01-04-2013
Publisher
Springer US
Published in
Journal of Immigrant and Minority Health / Issue 2/2013
Print ISSN: 1557-1912
Electronic ISSN: 1557-1920
DOI
https://doi.org/10.1007/s10903-012-9604-8

Other articles of this Issue 2/2013

Journal of Immigrant and Minority Health 2/2013 Go to the issue